Title: A Comparative Study of Small Dense low Density Lipoprotein levels in the Healthy and Diabetic Adult Individuals

Authors: Dr K. Harika Priyadarshini, Dr P.Nanda Kumar, B.Navya, Dr N.Vijaysam

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i8.196

Abstract

The present study was carried out to identify the differences between small dense LDL levels in apparently healthy individuals and diabetic adults.

Materials and Methods: The study was conducted in male and female subjects (n =200) aged between 49-60 years who are not on any lipid lowering drugs. The estimation of small dense LDL levels was done by sd LDL methodology.

Results and Discussion: In this study we found that there is an increase in small dense LDL levels in diabetic cases than in normal healthy adult individuals.

Conclusion: Diabetes is closely associated with small dense LDL, an atherogenic particle. It should be considered as an independent, potential risk factor and as a diagnostic biomarker to be used in conjunction with other biochemical markers for early diagnosis, assessment and follow up of diabetic complications.

Keywords: Diabetes, small dense LDL, Biochemical marker, Atherosclerosis.

References

  1. Essam Abd-Allha, Basma Badr Hassan, Mohamad Abduo, Seham Ahmad Omar, Hamdy Sliem; Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus; Indian Journal of Endocrinology and Metabolism / Jan-Feb 2014/Vol 18 |Issue 1
  2. Seema Abhijeet Kaveeshwar, Jon cornwall, the current state of diabetes mellitus in india, Australasian medical journal [AMJ 2014, 7, 1, 45-48]
  3. Gilson Soares Feitosa-Filho, Talita de Mattos Seydell, Alina Coutinho Rodrigues Feitosa, Raul Cavalcante Maranhão, José Antônio Franchini Ramires , Lipid Transfer to HDL in Type-2 Diabetic Patients: Associations with Microalbumi-nuria, Statin, and Insulin .Arq Bras Cardiol 2009;92(2):94-100
  4. Philipp A Gerber, Giatgen A Spinas & Kaspar Berneis. Small dense low-density lipoprotein particles: priority as a treat-ment target in Type 2 diabetes? Diabetes Manage. (2012) 2(1), 65–74 ISSN 1758-1907
  5. Ekaterina A. Ivanova, Veronika A. Myasoedova, Alexandra A. Melnichenko, Andrey V. Grechko, and Alexander N. Orekhov, Hindawi, Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases, Oxidative Medicine and Cellular Longevity, Volume 2017, Article ID 1273042, 10 pages
  6. Mutay Aslan, Filiz Ozcan, and Ertan Kucuksayan, Increased Small Dense LDL and Decreased Paraoxonase Enzyme Activity Reveals Formation of an Atherogenic Risk in Streptozotocin-Induced Diabetic Guinea Pigs, Journal of Diabetes Research Accepted 25 February 2013
  7. John J. Albers, April Slee, Jerome L.Fleg , Kevin D. O’Brien, Santica M. Marcovina, Relationship of baseline HDL subclasses, small dense Atherosclerosis 251 (2016) 454e459journal homepage: elsevier.com/locate/atherosclerosis
  8. Hao Shen, Yan Xu, Jingfen Lu Chunfang Ma, Yadong Zhou, Giong Li, Xu Chen, Ao Zhu and Guorong Shen, Shen et al;  Small dense low density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients. BMC Nephrology (2016) 17:143.  
  9. Ira J. Goldberg; Diabetic Dyslipidemia: Causes and Consequences, The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A
  10. Paul S. Jellinger, Chair; Yehuda Handelsman Paul D. RosenblitZachary T. Bloomgarden,; Vivian A. Fonseca, AlanJ.Garber ; American Association of Clinical Endocrinologists and American College of Endocrinology.Guidelines for management of dyslipidemia and prevention of cardiovascular disease endocrine practice, Vol 23 (suppl 2) April 2017
  11. Sheikh Ishaq, Iram Shabir, Arif A. Bhat, Imran Shafi, Saima Mushtaq, Parvaiz A. Shah1, Azra Baba2, Sabhiya Majid; Glycated Hemoglobin: A Marker of Circulating Lipids in Patients with Type 2 Diabetes from http://www.journalofdi-abetology.org on Friday, August 4, 2017, IP: 103.217.212.56]
  12. Toshiyuki Hayashia, Tsutomu Hiranoa, Takeshi Yamamotoa, Yasuki Itob, Mitsuru Adachia, . Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies, JapanMetabolism Clinical and Experimental 55 (2006) 879– 884
  13. Jimimol Thomas, K. Krishnakumar, L. Panayappan, K. Jayapraksah, Atherogenic Dyslipidemia andits Management in Diabetes; (SAJP) ISSN 2320-4206 (Online), Sch. Acad. J. Pharm., 2015; 4(4): 245-248 ISSN 2347-9531 (Print).
  14. Sunghwan Suh, Hyung-Doo Park, Sang-Man Jin, Hye Jeong Kim, Ji Cheol Bae, So Young Park, Mi Kyoung Park, . Diabetes mellitus, but not small dense low-density lipoprotein, is predictive of cardiovascular disease: A Korean community-based prospective cohort study, Journal of Diabetes Investigation, Volume 4, Issue 6, and November 2013
  15. Nahla N Younis,Handrean Soran1, Reena Sharma, Valentine Charlton-Menys1, Adam Greenstein1, Mohamed M Elseweidyand Paul N Durrington1,Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes; Diabetes & Vascular Disease Research ,7(4) 289–295 .

Corresponding Author

Dr Harika Priyadarshini

Assistant Professor, Department of Physiology,

Guntur Medical College, Guntur, AP

Email id: This email address is being protected from spambots. You need JavaScript enabled to view it.